ALBANY, N.Y., Jan. 17, 2018 /PRNewswire/ — AMRI, a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, announced that three of the company's analytical services experts will deliver a two-part presentation during MD&M West, Feb. 6-8 in Anaheim, Calif.

Brandon Zurawlow, associate director, container closure integrity testing; Frank Bieganousky, director, package and medical device testing; and John Iannone, director of extractables/leachables and impurities (E&L), will present "Ensuring Success when Bringing a Device to Market: Part 1 – Regulatory Testing and Part 2 – Product Development," beginning at 10:15 a.m., Thursday, Feb. 8. Session attendees will gain insights into mitigating risk and how to achieve regulatory acceptance when designing and qualifying complex systems, such as combination products. Topics will include material selection, process optimization, biocompatibility, CCIT, E&L, risk assessment, and device functionality.

"Medical device development professionals are seeking guidance in managing the changing regulatory landscape," said Iannone. "Understanding these requirements early-on has proven to drive a significantly more efficient product development process leading to a successful product release."

MD&M West is one of the industry's largest networking opportunities with more than 20,000 engineers and executives who are ready to forge business partnerships. AMRI will be featuring a variety of analytical services for medical devices and drug delivery, including E&L, biocompatibility, microbiology, mechanical and functional testing, CCIT, and packaging and distribution testing.

To arrange and schedule a meeting with AMRI (Booth No. 351) while attending MD&M, please make a request here.

SOURCE AMRI